|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/22 | |||
| C07K 16/28 | |||
| A61K 39/00 |
| (11) | Patento numeris | 3082857 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14821592.4 |
| Europos patento paraiškos padavimo data | 2014-12-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-10-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-07-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2014/078233 |
| Data | 2014-12-17 |
| (87) | Numeris | WO 2015/091655 |
| Data | 2015-06-25 |
| (30) | Numeris | Data | Šalis |
| 13198753 | 2013-12-20 | EP | |
| 14158331 | 2014-03-07 | EP |
| (72) |
KLEIN, Christian, CH
MUELLER, Philipp, DE
THOMAS, Markus, DE
ZIPPELIUS, Alfred, CH
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacher Strasse 124, 4070 Basel,
CH
|
| (54) | COMBINATION THERAPY WITH AN ANTI-ANG2 ANTIBODY AND A CD40 AGONIST |
| COMBINATION THERAPY WITH AN ANTI-ANG2 ANTIBODY AND A CD40 AGONIST |